Alloy introduces weight care program for menopausal and perimenopausal women
"It's amazing what you can learn by simply listening"
In a healthcare landscape often criticised for sidelining women’s needs, especially in midlife, Alloy is making a fresh push to put patients first — starting with weight. The company, co-founded by Anne Fulenwider and Monica Molenaar, has unveiled a new programme designed specifically for women navigating the complex, and often overlooked, physical and emotional challenges of menopause-related weight gain.
“We started Alloy Women’s Health because women in perimenopause and menopause were being overlooked, dismissed, and unheard,” the founders said in a joint statement.
“It was loud and clear to us that women everywhere were asking not only to be seen, but also for solutions that really work.”
Alloy’s new Weight Care Program aims to address this call. Rooted in both clinical expertise and lived experience, the initiative offers access to GLP-1 weight loss medications, personalised care, and a broader support system tailored for women in perimenopause and menopause.
The company cites a recent survey in which 80% of customers said symptoms such as weight gain, fatigue, and joint pain were major reasons for exploring GLP-1 medications. A further 60% expressed belief in the potential benefits of combining these drugs with Menopause Hormone Therapy (MHT), though many are seeking more guidance.
The programme, led by Alloy’s Clinical Director Dr. Michelle Montville, a board-certified OB-GYN and specialist in menopause and weight management, offers three medication options: FDA-approved Zepbound® and Wegovy®, as well as compounded liraglutide. All treatments are overseen by physicians with extensive experience in both menopause care and GLP-1 prescriptions.
But Alloy is quick to emphasise that medication is just one part of the equation. The programme also includes nutritional and lifestyle coaching, 24/7 telehealth support, progress tracking, support groups, and access to MHT where appropriate.
“In healthcare, listening to women is revolutionary,” said Fulenwider and Molenaar. “And it’s been the key to everything we’ve built at Alloy.”
At the heart of the initiative is a belief that menopausal weight gain is not simply a cosmetic issue, but a “deeply personal and emotional challenge” that requires understanding, empathy, and a scientific approach.
The launch of the Weight Care Program is another step in Alloy’s broader mission to redefine midlife healthcare for women. As the founders put it, “We believe women deserve to feel amazing in their bodies, inside and out—and we’re here to help.”